ID   MASP2_RAT               Reviewed;         685 AA.
AC   Q9JJS8; Q9JJP3; Q9QX83; Q9QX84; Q9QX85; Q9QX86; Q9QX87; Q9QX88; Q9QX89;
AC   Q9QX90; Q9QX91; Q9QXD4; Q9WUZ0;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   29-MAY-2024, entry version 161.
DE   RecName: Full=Mannan-binding lectin serine protease 2;
DE            EC=3.4.21.104;
DE   AltName: Full=MBL-associated serine protease 2;
DE   AltName: Full=Mannose-binding protein-associated serine protease 2;
DE            Short=MASP-2;
DE   Contains:
DE     RecName: Full=Mannan-binding lectin serine protease 2 A chain;
DE   Contains:
DE     RecName: Full=Mannan-binding lectin serine protease 2 B chain;
DE   Flags: Precursor;
GN   Name=Masp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBUNIT STRUCTURE,
RP   ACTIVATION BY PROTEOLYTIC CLEAVAGE, AND TISSUE SPECIFICITY.
RC   STRAIN=Fischer 344;
RX   PubMed=10586086;
RA   Stover C.M., Thiel S., Lynch N.J., Schwaeble W.J.;
RT   "The rat and mouse homologues of MASP-2 and MAp19, components of the
RT   mannan-binding lectin activation pathway of complement.";
RL   J. Immunol. 163:6848-6859(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15672593; DOI=10.1007/s00335-004-3006-8;
RA   Stover C.M., Lynch N.J., Hanson S.J., Windbichler M., Gregory S.G.,
RA   Schwaeble W.J.;
RT   "Organization of the MASP2 locus and its expression profile in mouse and
RT   rat.";
RL   Mamm. Genome 15:887-900(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-685 (ISOFORM 1), PROTEIN SEQUENCE OF
RP   N-TERMINUS, SUBUNIT STRUCTURE, GLYCOSYLATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND INTERACTION WITH MBL2.
RC   TISSUE=Liver;
RX   PubMed=10913141; DOI=10.1074/jbc.m004030200;
RA   Wallis R., Dodd R.B.;
RT   "Interaction of mannose-binding protein with associated serine proteases:
RT   effects of naturally occurring mutations.";
RL   J. Biol. Chem. 275:30962-30969(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 87-294 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=10092804;
RA   Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T.,
RA   Jensenius J.C., Schwaeble W.J.;
RT   "Two constituents of the initiation complex of the mannan-binding lectin
RT   activation pathway of complement are encoded by a single structural gene.";
RL   J. Immunol. 162:3481-3490(1999).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 20-299, HYDROXYLATION AT ASN-158,
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-103.
RX   PubMed=12743029; DOI=10.1093/emboj/cdg236;
RA   Feinberg H., Uitdehaag J.C.M., Davies J.M., Wallis R., Drickamer K.,
RA   Weis W.I.;
RT   "Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein
RT   associated serine protease-2.";
RL   EMBO J. 22:2348-2359(2003).
CC   -!- FUNCTION: Serum protease that plays an important role in the activation
CC       of the complement system via mannose-binding lectin. After activation
CC       by auto-catalytic cleavage it cleaves C2 and C4, leading to their
CC       activation and to the formation of C3 convertase.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Selective cleavage after Arg-223 in complement component C2 (-
CC         Ser-Leu-Gly-Arg-|-Lys-Ile-Gln-Ile) and after Arg-76 in complement
CC         component C4 (-Gly-Leu-Gln-Arg-|-Ala-Leu-Glu-Ile).; EC=3.4.21.104;
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Binds MBL2. Isoform 2 binds to
CC       MASP1. Binds SERPING1 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9JJS8-1; Sequence=Displayed;
CC       Name=2; Synonyms=MAp19;
CC         IsoId=Q9JJS8-2; Sequence=VSP_014638, VSP_014639;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver. Secreted in plasma.
CC       {ECO:0000269|PubMed:10586086}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10913141,
CC       ECO:0000269|PubMed:12743029}.
CC   -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate
CC       and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Dimerization and MBL2 binding requires calcium ions.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y19161; CAB65248.1; -; mRNA.
DR   EMBL; Y18565; CAB65382.1; -; mRNA.
DR   EMBL; Y18566; CAB65383.1; -; mRNA.
DR   EMBL; Y18567; CAB65384.1; -; mRNA.
DR   EMBL; Y18568; CAB65385.1; -; mRNA.
DR   EMBL; Y18569; CAB65386.1; -; mRNA.
DR   EMBL; Y18570; CAB65387.1; -; mRNA.
DR   EMBL; Y18571; CAB65388.1; -; mRNA.
DR   EMBL; Y18572; CAB65389.1; -; mRNA.
DR   EMBL; Y18573; CAB65390.1; -; mRNA.
DR   EMBL; Y18564; CAB70973.1; -; mRNA.
DR   EMBL; AJ277747; CAB90832.1; -; mRNA.
DR   EMBL; Y18285; CAB50738.1; -; mRNA.
DR   RefSeq; NP_742040.1; NM_172043.1.
DR   PDB; 1NT0; X-ray; 2.70 A; A/G=20-299.
DR   PDB; 5CIS; X-ray; 2.58 A; A=21-298.
DR   PDB; 5CKM; X-ray; 2.73 A; A=21-297.
DR   PDB; 5CKN; X-ray; 2.60 A; A/D=20-297.
DR   PDBsum; 1NT0; -.
DR   PDBsum; 5CIS; -.
DR   PDBsum; 5CKM; -.
DR   PDBsum; 5CKN; -.
DR   AlphaFoldDB; Q9JJS8; -.
DR   SMR; Q9JJS8; -.
DR   CORUM; Q9JJS8; -.
DR   STRING; 10116.ENSRNOP00000016317; -.
DR   MEROPS; S01.229; -.
DR   GlyCosmos; Q9JJS8; 3 sites, No reported glycans.
DR   GlyGen; Q9JJS8; 3 sites.
DR   iPTMnet; Q9JJS8; -.
DR   PhosphoSitePlus; Q9JJS8; -.
DR   PaxDb; 10116-ENSRNOP00000016317; -.
DR   PeptideAtlas; Q9JJS8; -.
DR   ABCD; Q9JJS8; 10 sequenced antibodies.
DR   GeneID; 64459; -.
DR   KEGG; rno:64459; -.
DR   AGR; RGD:620214; -.
DR   CTD; 10747; -.
DR   RGD; 620214; Masp2.
DR   eggNOG; KOG3627; Eukaryota.
DR   InParanoid; Q9JJS8; -.
DR   OrthoDB; 5394076at2759; -.
DR   PhylomeDB; Q9JJS8; -.
DR   BRENDA; 3.4.21.104; 5301.
DR   Reactome; R-RNO-166662; Lectin pathway of complement activation.
DR   Reactome; R-RNO-166663; Initial triggering of complement.
DR   Reactome; R-RNO-2855086; Ficolins bind to repetitive carbohydrate structures on the target cell surface.
DR   SABIO-RK; Q9JJS8; -.
DR   EvolutionaryTrace; Q9JJS8; -.
DR   PRO; PR:Q9JJS8; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISO:RGD.
DR   GO; GO:0001855; F:complement component C4b binding; ISO:RGD.
DR   GO; GO:0008233; F:peptidase activity; IDA:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0006956; P:complement activation; NAS:RGD.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001867; P:complement activation, lectin pathway; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd00033; CCP; 2.
DR   CDD; cd00041; CUB; 2.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 2.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 2.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   InterPro; IPR024175; Pept_S1A_C1r/C1S/mannan-bd.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24255; COMPLEMENT COMPONENT 1, S SUBCOMPONENT-RELATED; 1.
DR   PANTHER; PTHR24255:SF10; MANNAN-BINDING LECTIN SERINE PROTEASE 2; 1.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF00084; Sushi; 2.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001155; C1r_C1s_MASP; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00032; CCP; 2.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00179; EGF_CA; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57535; Complement control module/SCR domain; 2.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF49854; Spermadhesin, CUB domain; 2.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS50923; SUSHI; 2.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage; Calcium;
KW   Complement pathway; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Hydrolase; Hydroxylation; Immunity;
KW   Innate immunity; Metal-binding; Protease; Reference proteome; Repeat;
KW   Secreted; Serine protease; Signal; Sushi.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000269|PubMed:10913141"
FT   CHAIN           20..685
FT                   /note="Mannan-binding lectin serine protease 2"
FT                   /id="PRO_0000027604"
FT   CHAIN           20..443
FT                   /note="Mannan-binding lectin serine protease 2 A chain"
FT                   /id="PRO_0000027605"
FT   CHAIN           444..685
FT                   /note="Mannan-binding lectin serine protease 2 B chain"
FT                   /id="PRO_0000027606"
FT   DOMAIN          20..137
FT                   /note="CUB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          138..181
FT                   /note="EGF-like; calcium-binding"
FT   DOMAIN          184..296
FT                   /note="CUB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          298..363
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          364..431
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          444..683
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        482
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        531
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        632
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   BINDING         67
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         75
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         120
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         122
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         123
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         138
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT   BINDING         139
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT   BINDING         159
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT   BINDING         162
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   SITE            443..444
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         158
FT                   /note="(3R)-3-hydroxyasparagine"
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   CARBOHYD        285
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        641
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        72..90
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   DISULFID        152..165
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   DISULFID        167..180
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   DISULFID        184..211
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   DISULFID        241..259
FT                   /evidence="ECO:0000269|PubMed:12743029"
FT   DISULFID        300..348
FT                   /evidence="ECO:0000250"
FT   DISULFID        328..361
FT                   /evidence="ECO:0000250"
FT   DISULFID        366..411
FT                   /evidence="ECO:0000250"
FT   DISULFID        396..429
FT                   /evidence="ECO:0000250"
FT   DISULFID        433..551
FT                   /note="Interchain (between A and B chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059,
FT                   ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000255|PROSITE-
FT                   ProRule:PRU00302"
FT   DISULFID        597..617
FT                   /evidence="ECO:0000250"
FT   DISULFID        628..659
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         182..185
FT                   /note="ALCS -> EQSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10586086"
FT                   /id="VSP_014638"
FT   VAR_SEQ         186..685
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10586086"
FT                   /id="VSP_014639"
FT   CONFLICT        33
FT                   /note="L -> P (in Ref. 1; CAB90832)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        34
FT                   /note="G -> A (in Ref. 1; CAB65385/CAB65387/CAB65390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        506..507
FT                   /note="LI -> PH (in Ref. 1; CAB90832)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        622
FT                   /note="R -> A (in Ref. 1; CAB90832)"
FT                   /evidence="ECO:0000305"
FT   STRAND          27..31
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   TURN            33..36
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          44..50
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          55..65
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          74..81
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          84..89
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:1NT0"
FT   STRAND          109..118
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          129..138
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   TURN            141..143
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:5CKM"
FT   STRAND          151..159
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          177..182
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          185..189
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          191..197
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   TURN            199..202
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          210..216
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          221..227
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:5CKN"
FT   STRAND          241..249
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:5CKN"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          272..279
FT                   /evidence="ECO:0007829|PDB:5CIS"
FT   STRAND          290..297
FT                   /evidence="ECO:0007829|PDB:5CIS"
SQ   SEQUENCE   685 AA;  75667 MW;  0086154934509C64 CRC64;
     MRLLIVLGLL WSLVATLLGS KWPEPVFGRL VSLGFPEKYG NHQDRSWTLT APPGFRLRLY
     FTHFNLELSY RCEYDFVKLT SGTKVLATLC GQESTDTERA PGNDTFYSLG PSLKVTFHSD
     YSNEKPFTGF EAFYAAEDVD ECRTSLGDSV PCDHYCHNYL GGYYCSCRVG YILHQNKHTC
     SALCSGQVFT GRSGFLSSPE YPQPYPKLSS CAYNIRLEEG FSITLDFVES FDVEMHPEAQ
     CPYDSLKIQT DKREYGPFCG KTLPPRIETD SNKVTITFTT DESGNHTGWK IHYTSTAQPC
     PDPTAPPNGH ISPVQATYVL KDSFSVFCKT GFELLQGSVP LKSFTAVCQK DGSWDRPIPE
     CSIIDCGPPD DLPNGHVDYI TGPEVTTYKA VIQYSCEETF YTMSSNGKYV CEADGFWTSS
     KGEKSLPVCK PVCGLSTHTS GGRIIGGQPA KPGDFPWQVL LLGETTAAGA LIHDDWVLTA
     AHAVYGKTEA MSSLDIRMGI LKRLSLIYTQ AWPEAVFIHE GYTHGAGFDN DIALIKLKNK
     VTINRNIMPI CLPRKEAASL MKTDFVGTVA GWGLTQKGFL ARNLMFVDIP IVDHQKCATA
     YTKQPYPGAK VTVNMLCAGL DRGGKDSCRG DSGGALVFLD NETQRWFVGG IVSWGSINCG
     GSEQYGVYTK VTNYIPWIEN IINNF
//
